Featured MyStudies

Participating in a clinical trial, study, or survey has several potential benefits, including access to free and innovative treatment, free medical care, improvement of your psoriatic disease symptoms, and monetary compensation.

Your participation in research studies can help lead to safer, more effective treatment options for all those living with psoriatic disease.

Filter

5 Miles
Select study types...
Select disease states...

Make a Difference in Psoriasis & Pregnancy Research

Online Only
Research Study
Psoriatic Arthritis, Psoriasis

Are you pregnant and living with psoriasis? You can help advance critical research by joining the Psoriasis Pregnancy Study—a remote, observational study.

Learn More

The EVERLAST-B Study for Psoriasis - Now Enrolling

Multiple Locations
Clinical Trial
Psoriasis

If you’re living with moderate to severe psoriasis, you may qualify for the EVERLAST-B Study. The study is evaluating an investigational medication to see if it can help relieve the pain, itch, skin irritation, and other symptoms caused by psoriasis.

Learn More

The ORCA-SURGE Study for Psoriasis

Multiple Locations
Clinical Trial
Psoriasis

Research study for patients with moderate to severe plaque psoriasis.

Learn More

The Effects of Auditory Interventions on Anxiety

Online Only
Research Study, Survey, Clinical Trial
Psoriasis

Researchers want to learn if at-home audio sessions help anxiety levels in psoriasis patients.

Learn More

Palmoplantar Pustulosis (PPP) Study - Enrolling

Portland, Oregon
Clinical Trial
Psoriasis

Living with the discomfort and pain of Palmoplantar Pustulosis (PPP), a psoriasis subtype? A clinical research study in Portland is evaluating an investigational cream for skin improvement and symptom relief. No cost to participate, no insurance needed, and compensation with travel reimbursement may be available.

Learn More

SKYWAY-RD

Multiple Locations
Clinical Trial
Psoriatic Arthritis

This is a clinical research study testing the safety and efficacy of an investigational medication called SPY072 in the treatment of rheumatic diseases including psoriatic arthritis compared to a placebo (a substance that looks like the study drug but has no active medication). SPY072 has not been approved for any use anywhere in the world.

Learn More

Get Notified About Upcoming Trials

Sign up to receive information about clinical trials, studies, and surveys in your area – right to your inbox.

Sign up

Featured MyStudies represents promotional content from our partners. Information contained in these listings is for general informational purposes only and does not constitute an endorsement, recommendation, or certification of any kind by NPF. Persons participating in trials, studies, or surveys assume responsibility for their participation and are advised to discuss the information shown with their health care provider.

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2026 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.